ESCMID guideline for the diagnosis and management  of Candida diseases 2012: diagnostic procedures

M. Cuenca-Estrella; P. E. Verweij; M. C. Arendrup; S. Arikan-Akdagli; J. Bille; J. P. Donnelly; Henrik Elvang Jensen; C. Lass-Flörl; M. D. Richardson; M. Akova; M. Bassetti; T. Calandra; E. Castagnola; O. A. Cornely; J. Garbino; A. H. Groll; R. Herbrecht; W. W. Hope; B. J. Kullberg; O. Lortholary; W. Meersseman; G. Petrikkos; E. Roilides; C. Viscoli; A. J. Ullmann

doi:10.1111/1469-0691.12038

ESCMID guideline for the diagnosis and management of Candida diseases 2012: diagnostic procedures

M. Cuenca-Estrella, P. E. Verweij, M. C. Arendrup, S. Arikan-Akdagli, J. Bille, J. P. Donnelly, Henrik Elvang Jensen, C. Lass-Flörl, M. D. Richardson, M. Akova, M. Bassetti, T. Calandra, E. Castagnola, O. A. Cornely, J. Garbino, A. H. Groll, R. Herbrecht, W. W. Hope, B. J. Kullberg, O. LortholaryW. Meersseman, G. Petrikkos, E. Roilides, C. Viscoli, A. J. Ullmann

240 Citationer (Scopus)

Abstract

As the mortality associated with invasive Candida infections remains high, it is important to make optimal use of available diagnostic tools to initiate antifungal therapy as early as possible and to select the most appropriate antifungal drug. A panel of experts of the European Fungal Infection Study Group (EFISG) of the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) undertook a data review and compiled guidelines for the clinical utility and accuracy of different diagnostic tests and procedures for detection of Candida infections. Recommendations about the microbiological investigation and detection of candidaemia, invasive candidiasis, chronic disseminated candidiasis, and oropharyngeal, oesophageal, and vaginal candidiasis were included. In addition, remarks about antifungal susceptibility testing and therapeutic drug monitoring were made.

Originalsprog	Engelsk
Tidsskrift	Clinical Microbiology and Infection
Vol/bind	18
Udgave nummer	Suppl. s7
Sider (fra-til)	9-18
Antal sider	10
ISSN	1198-743X
DOI	https://doi.org/10.1111/1469-0691.12038
Status	Udgivet - dec. 2012

FN’s Verdensmål

Dette resultat bidrager til følgende verdensmål

Adgang til dokumentet

10.1111/1469-0691.12038

Citationsformater

Cuenca-Estrella, M., Verweij, P. E., Arendrup, M. C., Arikan-Akdagli, S., Bille, J., Donnelly, J. P., Jensen, H. E., Lass-Flörl, C., Richardson, M. D., Akova, M., Bassetti, M., Calandra, T., Castagnola, E., Cornely, O. A., Garbino, J., Groll, A. H., Herbrecht, R., Hope, W. W., Kullberg, B. J., ... Ullmann, A. J. (2012). ESCMID guideline for the diagnosis and management of Candida diseases 2012: diagnostic procedures. Clinical Microbiology and Infection, 18(Suppl. s7), 9-18. https://doi.org/10.1111/1469-0691.12038

Cuenca-Estrella, M, Verweij, PE, Arendrup, MC, Arikan-Akdagli, S, Bille, J, Donnelly, JP, Jensen, HE, Lass-Flörl, C, Richardson, MD, Akova, M, Bassetti, M, Calandra, T, Castagnola, E, Cornely, OA, Garbino, J, Groll, AH, Herbrecht, R, Hope, WW, Kullberg, BJ, Lortholary, O, Meersseman, W, Petrikkos, G, Roilides, E, Viscoli, C & Ullmann, AJ 2012, 'ESCMID guideline for the diagnosis and management of Candida diseases 2012: diagnostic procedures', Clinical Microbiology and Infection, bind 18, nr. Suppl. s7, s. 9-18. https://doi.org/10.1111/1469-0691.12038

@article{639cd63a61324c6ea657c942c8c66f48,

title = "ESCMID guideline for the diagnosis and management of Candida diseases 2012: diagnostic procedures",

abstract = "As the mortality associated with invasive Candida infections remains high, it is important to make optimal use of available diagnostic tools to initiate antifungal therapy as early as possible and to select the most appropriate antifungal drug. A panel of experts of the European Fungal Infection Study Group (EFISG) of the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) undertook a data review and compiled guidelines for the clinical utility and accuracy of different diagnostic tests and procedures for detection of Candida infections. Recommendations about the microbiological investigation and detection of candidaemia, invasive candidiasis, chronic disseminated candidiasis, and oropharyngeal, oesophageal, and vaginal candidiasis were included. In addition, remarks about antifungal susceptibility testing and therapeutic drug monitoring were made.",

author = "M. Cuenca-Estrella and Verweij, {P. E.} and Arendrup, {M. C.} and S. Arikan-Akdagli and J. Bille and Donnelly, {J. P.} and Jensen, {Henrik Elvang} and C. Lass-Fl{\"o}rl and Richardson, {M. D.} and M. Akova and M. Bassetti and T. Calandra and E. Castagnola and Cornely, {O. A.} and J. Garbino and Groll, {A. H.} and R. Herbrecht and Hope, {W. W.} and Kullberg, {B. J.} and O. Lortholary and W. Meersseman and G. Petrikkos and E. Roilides and C. Viscoli and Ullmann, {A. J.}",

year = "2012",

month = dec,

doi = "10.1111/1469-0691.12038",

language = "English",

volume = "18",

pages = "9--18",

journal = "Clinical Microbiology and Infection",

issn = "1198-743X",

publisher = "Elsevier",

number = "Suppl. s7",

}

TY - JOUR

T1 - ESCMID guideline for the diagnosis and management of Candida diseases 2012

T2 - diagnostic procedures

AU - Cuenca-Estrella, M.

AU - Verweij, P. E.

AU - Arendrup, M. C.

AU - Arikan-Akdagli, S.

AU - Bille, J.

AU - Donnelly, J. P.

AU - Jensen, Henrik Elvang

AU - Lass-Flörl, C.

AU - Richardson, M. D.

AU - Akova, M.

AU - Bassetti, M.

AU - Calandra, T.

AU - Castagnola, E.

AU - Cornely, O. A.

AU - Garbino, J.

AU - Groll, A. H.

AU - Herbrecht, R.

AU - Hope, W. W.

AU - Kullberg, B. J.

AU - Lortholary, O.

AU - Meersseman, W.

AU - Petrikkos, G.

AU - Roilides, E.

AU - Viscoli, C.

AU - Ullmann, A. J.

PY - 2012/12

Y1 - 2012/12

N2 - As the mortality associated with invasive Candida infections remains high, it is important to make optimal use of available diagnostic tools to initiate antifungal therapy as early as possible and to select the most appropriate antifungal drug. A panel of experts of the European Fungal Infection Study Group (EFISG) of the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) undertook a data review and compiled guidelines for the clinical utility and accuracy of different diagnostic tests and procedures for detection of Candida infections. Recommendations about the microbiological investigation and detection of candidaemia, invasive candidiasis, chronic disseminated candidiasis, and oropharyngeal, oesophageal, and vaginal candidiasis were included. In addition, remarks about antifungal susceptibility testing and therapeutic drug monitoring were made.

AB - As the mortality associated with invasive Candida infections remains high, it is important to make optimal use of available diagnostic tools to initiate antifungal therapy as early as possible and to select the most appropriate antifungal drug. A panel of experts of the European Fungal Infection Study Group (EFISG) of the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) undertook a data review and compiled guidelines for the clinical utility and accuracy of different diagnostic tests and procedures for detection of Candida infections. Recommendations about the microbiological investigation and detection of candidaemia, invasive candidiasis, chronic disseminated candidiasis, and oropharyngeal, oesophageal, and vaginal candidiasis were included. In addition, remarks about antifungal susceptibility testing and therapeutic drug monitoring were made.

U2 - 10.1111/1469-0691.12038

DO - 10.1111/1469-0691.12038

M3 - Journal article

SN - 1198-743X

VL - 18

SP - 9

EP - 18

JO - Clinical Microbiology and Infection

JF - Clinical Microbiology and Infection

IS - Suppl. s7

ER -

ESCMID guideline for the diagnosis and management of Candida diseases 2012: diagnostic procedures

Abstract

FN’s Verdensmål

Adgang til dokumentet

Fingeraftryk

Citationsformater